Roche Diagnostics Corp.: FDA filings under this applicant name
FDA lists 454 510(k) clearances under 4 spellings of the applicant name “Roche Diagnostics Corp.” (first 1999, latest 2026), plus 15 PMA and 4 De Novo decisions, across 154 product codes in 7 review panels. Median 510(k) review time under this name: 76 days. Since 2017 the median was 180 days, against 200 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Roche Diagnostics, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 12 | 138 |
| 2013 | 10 | 64 |
| 2014 | 16 | 89 |
| 2015 | 5 | 85 |
| 2016 | 6 | 164 |
| 2017 | 10 | 123 |
| 2018 | 7 | 132 |
| 2019 | 4 | 89 |
| 2020 | 3 | 160 |
| 2021 | 4 | 224 |
| 2022 | 10 | 217 |
| 2023 | 7 | 228 |
| 2024 | 3 | 266 |
| 2025 | 6 | 90 |
| 2026 | 12 | 111 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Roche Diagnostics Corp. took a median 180 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 200 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 58 | 58 |
| JJY | Multi-Analyte Controls, All Kinds (Assayed) | 22 | 22 |
| NBW | System, Test, Blood Glucose, Over The Counter | 19 | 19 |
| JIT | Calibrator, Secondary | 18 | 18 |
| GJS | Test, Time, Prothrombin | 14 | 14 |
| JIX | Calibrator, Multi-Analyte Mixture | 14 | 14 |
| LFR | Glucose Dehydrogenase, Glucose | 12 | 12 |
| DKZ | Enzyme Immunoassay, Amphetamine | 10 | 10 |
| SEI | Qualitative And Quantitative Hepatitis B Virus Antibody Assays | 10 | 2 |
| CGN | Acid, Folic, Radioimmunoassay | 7 | 7 |
Plus 144 more product codes.
Review panels
- Clinical Chemistry (261)
- Clinical Toxicology (72)
- Immunology (58)
- Microbiology (48)
- Hematology (30)
- General Hospital (2)
- Pathology (2)
Most recent Roche Diagnostics Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K260233 | Elecsys EBV IgM | LJN | 2026-10-02 | 249 |
| K260232 | Elecsys EBV VCA IgG | LSE | 2026-10-02 | 249 |
| K260221 | Elecsys EBV EBNA IgG | LSE | 2026-10-02 | 249 |
| K261686 | Elecsys Phospho-Tau (217P) Plasma | SET | 2026-08-19 | 90 |
| K252323 | cobas pulse blood glucose monitoring system | PZI | 2026-06-12 | 322 |
| K252280 | Elecsys Anti-SARS-CoV-2 S | QVP | 2026-04-13 | 265 |
| K260049 | Elecsys Anti-HBc IgM | SEI | 2026-04-07 | 90 |
| K260048 | Elecsys Anti-HAV IgM | LOL | 2026-04-07 | 90 |
| K260046 | Elecsys Anti-HBc II | SEI | 2026-04-07 | 90 |
| K260026 | Tina-quant Cardiac high sensitivity CRP III | NQD | 2026-04-02 | 87 |
444 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN260027 | De Novo | Quantitative Hepatitis B Surface Antigen | 2026-10-20 |
| P190034 | PMA | Elecsys Anti-HBs II, PreciControl Anti-HBs, Anti-HBs CalCheck | 2021-02-23 |
| P190005 | PMA | Elecsys Anti-HBe, PreciControl Anti-HBe | 2021-02-03 |
| P160019 | PMA | Elecsys HBsAg II/Elecsys HBsAg Confirmatory Test/ PreciControl HBsAg II | 2016-12-23 |
| DEN150057 | De Novo | Anti-Müllerian Hormone Test System | 2016-12-19 |
Recalls
240 product recalls in 107 recall events; 0 initiated in the last five years. Most recent: 2019-06-03.
85 product recalls in 57 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 3 initiated in the last five years. Most often: Roche Diagnostics Operations, Inc. (73), Roche Diabetes Care, Inc. (7), Roche Diagnostics Operations, inc. (3).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Roche Diagnostics Corp. (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via MRZ)
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter) (via MRZ)
- G0008 — Administration of influenza virus vaccine (via PSZ)
- E0785 — Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement (via MRZ)
FDA spellings included
FDA records this applicant under 4 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Roche Diagnostics Corp. (276)
- Roche Diagnostics (190)
- Roche Diagnostics Corporation (6)
- Roche Diagnostics, Inc. (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Roche Diagnostic Systems, Inc. (296 510(k)s)
- Roche Molecular Systems, Inc. (52 510(k)s)
- Roche Medical Electronics, Inc. (16 510(k)s)
- Roche Diagnostics Operations (Rdo) (14 510(k)s)
- Roche Analytical Instruments, Inc. (11 510(k)s)
- Roche Diabetes Care, Inc. (10 510(k)s)
- Roche Diagnostics Operations (7 510(k)s)
- Roche Diagnostics GmbH (5 510(k)s)
- Roche Diagnostics/Boehringer Mannheim GmbH (3 510(k)s)
- Roche (2 510(k)s)
- Roche Diabetes Care GmbH (2 510(k)s)
- Roche Professional Diagnostics (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Roche Diagnostics Corp.?
FDA lists 454 510(k) clearances under 4 spellings of the applicant name “Roche Diagnostics Corp.” (first 1999, latest 2026), plus 15 PMA and 4 De Novo decisions, across 154 product codes in 7 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Roche Diagnostics Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Roche Diagnostics Corp. is 76 days. Since 2017: 180 days, versus 200 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Roche Diagnostics Corp.?
The most frequent FDA product codes under this applicant name are JJX (Single (Specified) Analyte Controls (Assayed And Unassayed), 58); JJY (Multi-Analyte Controls, All Kinds (Assayed), 22); NBW (System, Test, Blood Glucose, Over The Counter, 19).
Next steps
- See all 454 Roche Diagnostics Corp. clearances with predicates and recalls
- Run predicate analysis for product code JJX, Roche Diagnostics Corp.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.